The Canadian aerospace and defense company said Friday the transaction initially announced in October 2023 is subject to customary adjustments and proceeds from the deal will enable it to streamline its core businesses’ operating model and portfolio.
The divestiture of CAE’s health care business will also support technology advancement, market leadership and cost structure optimization.
In a separate announcement, Jeff Evans, president of CAE Healthcare, said the integration of the global CAE Healthcare team into Madison Industries will expand the reach of the former’s simulation technology.
“This dedicated focus will allow us to progress simulation innovation and improve clinical outcomes with the most complete set of healthcare training tools available,” he added.
The Department of State has awarded spots on a multiple-award indefinite-delivery/indefinite-quantity contract with a combined potential value of $10 billion…
Brian Hobbs has been appointed CEO of Clarity Innovations, effective March 2, the company announced Tuesday. He succeeds founder and long-serving CEO Wes…
The Federal Aviation Administration has awarded a potential five-year, $437.4 million contract to ASRC Federal Advanced Research to provide second-level…
